Posaconazole

Noxafil, Noxafil PowderMix, and generics
Antifungal agent

Descriptive text is not available for this imageDescriptive text is not available for this imageDescriptive text is not available for this imageDescriptive text is not available for this imageDescriptive text is not available for this image
C3YesYesNo
Key
  • Delayed release tabs: 100 mg
  • Injection: 300 mg/16.7 mL (16.7 mL); contains EDTA and sulfobutyl ether-β-cyclodextrin (SBECD)
  • Oral suspension: 40 mg/mL (105 mL); contains polysorbate 80 and sodium benzoate
  • Delayed release oral suspension (Noxafil PowderMix): 300 mg powder packet to be mixed with 9 mL of mixing liquid to yield a 30 mg/mL oral suspension (8 powder packets); contains sorbitol

There's more to see -- the rest of this topic is available only to subscribers.